- Home
- ECOR vs BRFH Comparison
ECOR vs BRFH Comparison
Compare ECOR & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- BRFH
- Stock Information
- Founded
- ECOR 2005
- BRFH 2005
- Country
- ECOR United States
- BRFH United States
- Employees
- ECOR N/A
- BRFH N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BRFH Packaged Foods
- Sector
- ECOR Health Care
- BRFH Consumer Staples
- Exchange
- ECOR Nasdaq
- BRFH Nasdaq
- Market Cap
- ECOR 40.1M
- BRFH 43.8M
- IPO Year
- ECOR 2018
- BRFH N/A
- Fundamental
- Price
- ECOR $6.02
- BRFH $2.40
- Analyst Decision
- ECOR Strong Buy
- BRFH Strong Buy
- Analyst Count
- ECOR 2
- BRFH 1
- Target Price
- ECOR $25.50
- BRFH $4.50
- AVG Volume (30 Days)
- ECOR 130.4K
- BRFH 9.5K
- Earning Date
- ECOR 05-07-2025
- BRFH 05-01-2025
- Dividend Yield
- ECOR N/A
- BRFH N/A
- EPS Growth
- ECOR N/A
- BRFH N/A
- EPS
- ECOR N/A
- BRFH N/A
- Revenue
- ECOR $25,182,000.00
- BRFH $10,717,000.00
- Revenue This Year
- ECOR $32.20
- BRFH $41.20
- Revenue Next Year
- ECOR $46.27
- BRFH $42.03
- P/E Ratio
- ECOR N/A
- BRFH N/A
- Revenue Growth
- ECOR 57.09
- BRFH 31.87
- 52 Week Low
- ECOR $5.02
- BRFH $1.03
- 52 Week High
- ECOR $19.49
- BRFH $4.61
- Technical
- Relative Strength Index (RSI)
- ECOR 33.07
- BRFH 32.92
- Support Level
- ECOR $5.20
- BRFH $2.00
- Resistance Level
- ECOR $6.47
- BRFH $2.83
- Average True Range (ATR)
- ECOR 0.71
- BRFH 0.31
- MACD
- ECOR 0.33
- BRFH -0.04
- Stochastic Oscillator
- ECOR 49.26
- BRFH 27.78
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About BRFH Barfresh Food Group Inc.
Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.